IL-5-Induced Hypereosinophilia Suppresses the Antigen-Induced Immune Response via a TGF-β-Dependent Mechanism1

Although eosinophils play an essential role in allergic inflammation, their role has recently been under controversy. Epidemic studies suggest that hypereosinophilia induced by parasite infection could suppress subsequent Ag sensitization, although the mechanism has not been fully clarified. In this study, we investigated whether eosinophils could suppress the Ag-specific immune response in the airway. BALB/c mice were sensitized and airway challenged with OVA. Systemic hypereosinophilia was induced by delivery of an IL-5-producing plasmid. IL-5 gene delivery suppressed the Ag-specific proliferation and cytokine production of CD4+ T cells in the spleen. IL-5 gene delivery before OVA sensitization significantly suppressed airway eosinophilia and hyperresponsiveness provoked by subsequent OVA airway challenge, while delivery during the OVA challenge did not suppress them. This IL-5-induced immune suppression was abolished in eosinophil-ablated mice, suggesting an essential role of eosinophils. IL-5 treatment increased the production of TGF-β1 in the spleen, and we demonstrated that the main cellular source of TGF-β1 production was eosinophils, using eosinophil-ablated mice and depletion study. TGF-β1, but not IL-5 itself, suppressed the Ag-specific immune response of CD4+ T cells in vitro. Furthermore, IL-5 treatment enhanced phosphorylation of Smad2 in CD4+ T cells. Finally, a TGF-β type I receptor kinase inhibitor restored this IL-5-induced immune suppression both in vitro and in vivo. These results suggest that IL-5-induced hypereosinophilia could suppress sensitization to Ag via a TGF-β-dependent mechanism, thus suppressed allergic airway inflammation. Therefore, hypereosinophilia could reveal an immunosuppressive effect in the early stage of Ag-induced immune response.

[1]  N. Malla,et al.  Serum cytokine levels in human ascariasis and toxocariasis , 2006, Parasitology Research.

[2]  N. Lee,et al.  Eosinophil degranulation: an evolutionary vestige or a universally destructive effector function? , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[3]  J. Miyazaki,et al.  In Vivo IL-10 Gene Delivery Suppresses Airway Eosinophilia and Hyperreactivity by Down-Regulating APC Functions and Migration without Impairing the Antigen-Specific Systemic Immune Response in a Mouse Model of Allergic Airway Inflammation1 , 2005, The Journal of Immunology.

[4]  Kazuhiko Yamamoto,et al.  Antigen-sensitized CD4+CD62Llow memory/effector T helper 2 cells can induce airway hyperresponsiveness in an antigen free setting , 2005, Respiratory research.

[5]  Kazuhiko Yamamoto,et al.  A Novel Role of Cysteinyl Leukotrienes to Promote Dendritic Cell Activation in the Antigen-Induced Immune Responses in the Lung , 2004, The Journal of Immunology.

[6]  S. Orkin,et al.  A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.

[7]  E. Lenkiewicz,et al.  Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils , 2004, Science.

[8]  S. Phipps,et al.  A role for eosinophils in airway remodelling in asthma. , 2004, Trends in immunology.

[9]  James J. Lee,et al.  Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen , 2004, Journal of leukocyte biology.

[10]  Peter R. Galle,et al.  Cutting Edge: TGF-β Induces a Regulatory Phenotype in CD4+CD25− T Cells through Foxp3 Induction and Down-Regulation of Smad7 , 2004, The Journal of Immunology.

[11]  P. Crocker,et al.  The murine inhibitory receptor mSiglec‐E is expressed broadly on cells of the innate immune system whereas mSiglec‐F is restricted to eosinophils , 2004, European journal of immunology.

[12]  Justus G. Müller,et al.  Helminth infection modulates the development of allergen-induced airway inflammation. , 2004, International immunology.

[13]  R. Lumsden Cytological studies on the absorptive surfaces of cestodes , 2004, Zeitschrift für Parasitenkunde.

[14]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[15]  Rick M. Maizels,et al.  Immune Regulation by helminth parasites: cellular and molecular mechanisms , 2003, Nature Reviews Immunology.

[16]  J. Auwerx,et al.  Peroxisome Proliferator–activated Receptors α and γ Down-regulate Allergic Inflammation and Eosinophil Activation , 2003, The Journal of experimental medicine.

[17]  H. Kita,et al.  Marked Airway Eosinophilia Prevents Development of Airway Hyper-responsiveness During an Allergic Response in IL-5 Transgenic Mice1 , 2003, The Journal of Immunology.

[18]  D. Adamko,et al.  The eosinophil as a therapeutic target in asthma: beginning of the end, or end of the beginning? , 2003, Current opinion in pharmacology.

[19]  D. Strachan,et al.  Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics. , 2003, The Journal of allergy and clinical immunology.

[20]  James J. Lee,et al.  A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies , 2003 .

[21]  A. Kay,et al.  Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. , 2003, American journal of respiratory and critical care medicine.

[22]  D. Taub,et al.  Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis. , 2002, Blood.

[23]  M. Roncarolo,et al.  The Role of IL-10 and TGF-β in the Differentiation and Effector Function of T Regulatory Cells , 2002, International Archives of Allergy and Immunology.

[24]  S. Phipps,et al.  The Relationship Between Allergen-Induced Tissue Eosinophilia and Markers of Repair and Remodeling in Human Atopic Skin1 , 2002, The Journal of Immunology.

[25]  J. Bach,et al.  The effect of infections on susceptibility to autoimmune and allergic diseases. , 2002, The New England journal of medicine.

[26]  S. Orkin,et al.  Targeted Deletion of a High-Affinity GATA-binding Site in the GATA-1 Promoter Leads to Selective Loss of the Eosinophil Lineage In Vivo , 2002, The Journal of experimental medicine.

[27]  Xiping Xu,et al.  Ascaris lumbricoides infection is associated with increased risk of childhood asthma and atopy in rural China. , 2002, American journal of respiratory and critical care medicine.

[28]  Maria Yazdanbakhsh,et al.  Allergy, parasites, and the hygiene hypothesis. , 2002, Science.

[29]  R. Flavell,et al.  Transforming growth factor-β in T-cell biology , 2002, Nature Reviews Immunology.

[30]  J. Miyazaki,et al.  Intravenous delivery of naked plasmid DNA for in vivo cytokine expression. , 2001, Biochemical and biophysical research communications.

[31]  D. Dombrowicz,et al.  Eosinophils, allergy and parasites. , 2001, Current opinion in immunology.

[32]  A. Woodcock,et al.  Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study , 2001, The Lancet.

[33]  D. Liu,et al.  Hydrodynamics-based gene delivery. , 2001, Current opinion in molecular therapeutics.

[34]  T. Nolan,et al.  Infection of mice with the helminth Strongyloides stercoralis suppresses pulmonary allergic responses to ovalbumin , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[35]  K. Chung,et al.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response , 2000, The Lancet.

[36]  B. Lell,et al.  Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10 , 2000, The Lancet.

[37]  R. Flavell,et al.  Cutting Edge: TGF-β Inhibits Th Type 2 Development Through Inhibition of GATA-3 Expression , 2000, The Journal of Immunology.

[38]  Yamada,et al.  Allergen‐induced airway inflammation and bronchial responsiveness in interleukin‐5 receptor α chain‐deficient mice , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[39]  R. Tanaka,et al.  Noninvasive system for evaluating the allergen-specific airway response in a murine model of asthma. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[40]  D. Wong,et al.  IL-4-Dependent Regulation of TGF-α and TGF-β1 Expression in Human Eosinophils , 1998, The Journal of Immunology.

[41]  R. Martin,et al.  Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. , 1997, American journal of respiratory cell and molecular biology.

[42]  E. Gelfand,et al.  Interleukin-5 Expression in the Lung Epithelium of Transgenic Mice Leads to Pulmonary Changes Pathognomonic of Asthma , 1997, The Journal of experimental medicine.

[43]  J. Miyazaki,et al.  Intramuscular injection of expression plasmid DNA is an effective means of long-term systemic delivery of interleukin-5. , 1997, Biochemical and biophysical research communications.

[44]  E. Gelfand,et al.  Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. , 1997, American journal of respiratory and critical care medicine.

[45]  A. Issekutz,et al.  Quantitation of eosinophil and neutrophil infiltration into rat lung by specific assays for eosinophil peroxidase and myeloperoxidase. Application in a Brown Norway rat model of allergic pulmonary inflammation. , 1996, Journal of immunological methods.

[46]  M. Jordana,et al.  Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. , 1996, American journal of respiratory cell and molecular biology.

[47]  P. Foster,et al.  Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model , 1996, The Journal of experimental medicine.

[48]  K. Takatsu,et al.  Evaluation of airway hyperreactivity in interleukin-5 transgenic mice. , 1995, International archives of allergy and immunology.

[49]  T. Mosmann,et al.  Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. , 1994, Journal of immunology.

[50]  L. Lichtenstein,et al.  Immunological aspects of allergic asthma. , 1994, Annual review of immunology.

[51]  C. Harley,et al.  Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). , 1992, The Journal of clinical investigation.

[52]  C. Sanderson,et al.  Interleukin-5, eosinophils, and disease. , 1992, Blood.

[53]  N. Yamaguchi,et al.  In vivo administration of antibody to murine IL-5 receptor inhibits eosinophilia of IL-5 transgenic mice. , 1991, International immunology.

[54]  P. Venge,et al.  Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. , 1991, The Journal of allergy and clinical immunology.

[55]  J. Miyazaki,et al.  Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production , 1991, The Journal of experimental medicine.

[56]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[57]  C. Sanderson,et al.  Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. , 1989, Blood.

[58]  J. Gamble,et al.  Recombinant human interleukin 5 is a selective activator of human eosinophil function , 1988, The Journal of experimental medicine.